ESC 365 - Systemic versus site targeted treatment of neoatherosclerosis.

ESC Premium Access

Systemic versus site targeted treatment of neoatherosclerosis.

Session: ESC Grants for Medical Research Innovation

Topic: Atherosclerosis

Speaker: Doctor M. Joner (Munich, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Michael Joner

German Heart Center of Munich, Munich (Germany)

7 presentations

0 follower

4 more presentations in this session

Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).

Speaker: Doctor J. Soria Fernandez (Sant Pau, ES)

The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.

Speaker: Professor T. Heidt (Buhl, DE)

Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).

Speaker: Doctor D. Tregouet (Paris, FR)

Access the full session

ESC Grants for Medical Research Innovation

Speakers: Doctor M. Joner, Doctor J. Soria Fernandez, Associate Professor C. Christersson, Professor T. Heidt, Doctor D. Tregouet

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources